Works matching IS 17555914 AND DT 2012 AND VI 30 AND IP 2
Results: 13
Reconstituted HDL in Acute Coronary Syndromes.
- Published in:
- Cardiovascular Therapeutics, 2012, v. 30, n. 2, p. e51, doi. 10.1111/j.1755-5922.2010.00221.x
- By:
- Publication type:
- Article
Two Coronary 'Orphan' Diseases in Search of Clinical Consideration: Coronary Syndromes X and Y.
- Published in:
- Cardiovascular Therapeutics, 2012, v. 30, n. 2, p. e58, doi. 10.1111/j.1755-5922.2010.00232.x
- By:
- Publication type:
- Article
Allopurinol Attenuates Oxidative Stress and Cardiac Fibrosis in Angiotensin II-Induced Cardiac Diastolic Dysfunction.
- Published in:
- Cardiovascular Therapeutics, 2012, v. 30, n. 2, p. 117, doi. 10.1111/j.1755-5922.2010.00243.x
- By:
- Publication type:
- Article
From Eggs to Hearts: What Is the Link between Cyclic ADP-Ribose and Ryanodine Receptors?
- Published in:
- Cardiovascular Therapeutics, 2012, v. 30, n. 2, p. 109, doi. 10.1111/j.1755-5922.2010.00236.x
- By:
- Publication type:
- Article
Disruption of Coronary Vasomotor Function: The Coronary Spasm Syndrome.
- Published in:
- Cardiovascular Therapeutics, 2012, v. 30, n. 2, p. e66, doi. 10.1111/j.1755-5922.2010.00235.x
- By:
- Publication type:
- Article
Oxidative Stress Impairs Endothelial Function in Nondipper Hypertensive Patients.
- Published in:
- Cardiovascular Therapeutics, 2012, v. 30, n. 2, p. 85, doi. 10.1111/j.1755-5922.2010.00183.x
- By:
- Publication type:
- Article
Chronotropic Incompentence and Functional Capacity in Chronic Heart Failure: No Role of β-Blockers and β-Blocker Dose.
- Published in:
- Cardiovascular Therapeutics, 2012, v. 30, n. 2, p. 100, doi. 10.1111/j.1755-5922.2010.00184.x
- By:
- Publication type:
- Article
Thrombolytics and Myocardial Infarction.
- Published in:
- Cardiovascular Therapeutics, 2012, v. 30, n. 2, p. e81, doi. 10.1111/j.1755-5922.2010.00239.x
- By:
- Publication type:
- Article
Neurocardiology: Therapeutic Implications for Cardiovascular Disease.
- Published in:
- Cardiovascular Therapeutics, 2012, v. 30, n. 2, p. e89, doi. 10.1111/j.1755-5922.2010.00244.x
- By:
- Publication type:
- Article
Simvastatin Inhibits Glucose-Stimulated Vascular Smooth Muscle Cell Migration Involving Increased Expression of RhoB and a Block of Ras/Akt Signal.
- Published in:
- Cardiovascular Therapeutics, 2012, v. 30, n. 2, p. 75, doi. 10.1111/j.1755-5922.2010.00226.x
- By:
- Publication type:
- Article
ARIES-3: Ambrisentan Therapy in a Diverse Population of Patients with Pulmonary Hypertension.
- Published in:
- Cardiovascular Therapeutics, 2012, v. 30, n. 2, p. 93, doi. 10.1111/j.1755-5922.2011.00279.x
- By:
- Publication type:
- Article
Biomarkers in Atrial Fibrillation, Ventricular Arrhythmias, and Sudden Cardiac Death.
- Published in:
- Cardiovascular Therapeutics, 2012, v. 30, n. 2, p. e74, doi. 10.1111/j.1755-5922.2010.00238.x
- By:
- Publication type:
- Article
Lipid-Altering Efficacy of Ezetimibe/Simvastatin 10/20 mg Compared to Rosuvastatin 10 mg in High-Risk Patients with and without Type 2 Diabetes Mellitus Inadequately Controlled Despite Prior Statin Monotherapy.
- Published in:
- Cardiovascular Therapeutics, 2012, v. 30, n. 2, p. 61, doi. 10.1111/j.1755-5922.2010.00181.x
- By:
- Publication type:
- Article